Analyst Price Targets — OKYO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 10:38 am | — | H.C. Wainwright | $5.00 | $1.69 | StreetInsider | OKYO Pharma Ltd. (OKYO) PT Lowered to $5 at H.C. WainwrightMember Login |
| January 29, 2026 11:52 am | Yi Chen | H.C. Wainwright | $7.00 | $1.96 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO) |
Latest News for OKYO
Delta Air Lines Inc (NYSE:DAL) reaffirmed its full-year earnings outlook despite higher fuel costs, a move Bank of America said underscores the carrier's...
US banks could deliver broad earnings beats as strong capital markets activity, resilient economic conditions and improving wealth management flows support...
First Hawaiian, Inc. (NASDAQ:FHB) has agreed to acquire TriCo Bancshares (NASDAQ:TCBK), a combination the bank said will create the leading Pacific banking...
Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) reported record June revenue of NT$442.7 billion (about US$13.2 billion), as strong demand for its...
OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week reported positive feedback from its Type D meeting with the US Food and Drug Administration (FDA), providing greater regulatory clarity as the company advances urcosimod toward a global Phase 3 pivotal study for neuropathic corneal pain (NCP). Chief executive Robert Dempsey said the FDA's feedback supports a streamlined development strategy that could allow the company…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OKYO.
U.S. House Trading
No House trades found for OKYO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.